GC
TWST icon

Guggenheim Capital’s Twist Bioscience TWST Stock Holding History

Guggenheim Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Sell
14,985
-7,836
-34% -$510K 0.01% 833
2026
Q1 		$1.08M Buy
22,821
+393
+2% +$17.6K 0.01% 968
2025
Q4 		$711K Sell
22,428
-1,312
-6% -$40.9K 0.01% 1104
2025
Q3 		$668K Buy
23,740
+2,503
+12% +$75.8K ﹤0.01% 1070
2025
Q2 		$781K Buy
21,237
+2,065
+11% +$71.3K 0.01% 980
2025
Q1 		$753K Buy
19,172
+107
+0.6% +$4.82K 0.01% 1008
2024
Q4 		$886K Sell
19,065
-8,645
-31% -$391K 0.01% 975
2024
Q3 		$1.25M Buy
27,710
+2,766
+11% +$132K 0.01% 1000
2024
Q2 		$1.23M Buy
24,944
+16,911
+211% +$690K 0.01% 1014
2024
Q1 		$276K Sell
8,033
-111
-1% -$4.01K ﹤0.01% 1684
2023
Q4 		$300K Sell
8,144
-31,183
-79% -$721K ﹤0.01% 1659
2023
Q3 		$797K Sell
39,327
-6,606
-14% -$145K 0.01% 1207
2023
Q2 		$940K Sell
45,933
-1,491
-3% -$22.3K 0.01% 1188
2023
Q1 		$715K Buy
47,424
+10,099
+27% +$223K 0.01% 1334
2022
Q4 		$889K Buy
37,325
+7,468
+25% +$217K 0.01% 1224
2022
Q3 		$1.05M Buy
+29,857
New +$1.27M 0.01% 1119
2022
Q1 		– Sell
-23,420
Closed -$1.81M – 2187
2021
Q4 		$1.81M Buy
23,420
+1,299
+6% +$133K 0.01% 1100
2021
Q3 		$2.37M Buy
22,121
+767
+4% +$87.8K 0.01% 972
2021
Q2 		$2.85M Buy
21,354
+1,197
+6% +$139K 0.02% 912
2021
Q1 		$2.5M Buy
20,157
+2,327
+13% +$353K 0.02% 920
2020
Q4 		$2.52M Buy
+17,830
New +$1.98M 0.02% 872

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Guggenheim Capital's TWST Position: Q2 2026 in Review

Guggenheim Capital reduced its Twist Bioscience (TWST) stake by 34% in Q2 2026, selling an estimated $510K and leaving 14,985 shares worth $1.54M. The position accounts for 0.01% of the portfolio, ranked #833.

Guggenheim Capital first reported a position in TWST in Q4 2020 and has held it in 21 quarters since. The position peaked at $2.85M in Q2 2021. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Guggenheim Capital held 14,985 shares of Twist Bioscience worth $1.54M as of Q2 2026.
  • Guggenheim Capital sold 7,836 Twist Bioscience shares in Q2 2026, an estimated $510K.
  • Twist Bioscience made up 0.01% of Guggenheim Capital's portfolio in Q2 2026, its #833 holding.
  • Guggenheim Capital first reported a position in Twist Bioscience in Q4 2020 and has held it in 21 quarters since.
  • Guggenheim Capital's Twist Bioscience position peaked at $2.85M in Q2 2021.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.